New research indicates that people who stop taking the blood thinner warfarin over concerns about gastrointestinal bleeding raise their risk of blood clots and death if they remain off the drug, according to U.S. News and World Report.
Warfarin makes it harder for clots to form and block the blood stream, and is prescribed to ward off conditions such as stroke that are caused by blood clots. It also raises ...
continue reading...An article in the Journal of the American Medical Association alleges that an effort by the U.S. Food and Drug Administration to speed approval of new medicines has led to drugs making it onto the market without proper safety analysis.
The article specifically mentions the blood thinner Pradaxa, the Wall Street Journal reports.
The JAMA article is by Thomas J. Moore, who has written two books on drug safety and is ...
continue reading...A report in USA Today concerns the legal action by hundreds of plaintiffs who used the blood-thinner Pradaxa, stating that it may amount to “the country’s next blockbuster civil settlement.”
The U.S. Food and Drug Administration approved Pradaxa, manufactured by German pharmaceutical giant Boehringer Ingelheim, in 2010. At the time, it was promoted as the first replacement for the commonly used blood thinner warfarin, known by the brand ...
continue reading...A column by Dr. Anthony L. Komaroff in North Carolina’s Daily Reflector cautions about the effects of drug interactions for patients taking the medication warfarin – an anticoagulant, or blood thinner.
Komaroff writes that some antibiotics and antifungal drugs increase warfarin’s ability to stop blood clotting, but others do the opposite. Some topical antibiotics that are applied directly to the skin can also interfere with warfarin. He recommends that anyone ...
continue reading...A report on the Website for ABC’s Channel 13 out of Ohio deals with attempts by Pfizer Inc. and Bristol-Myers Squibb Co. to get federal regulators to approve their experimental anticlotting drug Eliquis.
The U.S. Food and Drug Administration once again delayed that approval, with the agency saying it wants more information on “data management and verification” from a huge international study examining how well Eliquis prevented strokes in patients ...
continue reading...A story in the Houston Press spotlights the growing health concerns that many medical professionals have about the blood thinner Pradaxa, which manufacturer Boehringer Ingelheim acknowledges has been linked to more than 260 deaths.
The Houston Press article mentions the case of Loraine Franklin, an 80-year-old former teacher who died of an intercranial hemorrhage after she fell on her kitchen floor.
Franklin’s daughters say ...
continue reading...
